CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III Gliomas
Clinical trial NCT02766270 · UNKNOWN
Trial details
- NCT number
- NCT02766270
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-26
- Primary completion
- 2017-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.